Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
JHEP Rep
; 2(5): 100142, 2020 Oct.
Article
em En
| MEDLINE
| ID: mdl-32775976
CLDQ, Chronic Liver Disease Questionnaire; CLDQ-NAFLD, Chronic Liver Disease Questionnaire Non-Alcoholic Fatty Liver Disease; CRF, case record form; Cost of illness; Cross-sectional studies; EU5, five European; Europe; FIB-4, Fibrosis-4; GAIN, Global Assessment of the Impact of NASH; HRQoL, health-related quality of life; NAFL non-alcoholic fatty liver NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; Non-alcoholic steatohepatitis; OTC, over-the-counter; PPIE, Patient Public Involvement Engagement; T2DM, type 2 diabetes mellitus
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Health_economic_evaluation
/
Risk_factors_studies
Idioma:
En
Revista:
JHEP Rep
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Reino Unido